retatrutide who makes it Lilly Prepares for FDA Filing Following Additional Phase 3 Data in Diabetes, CVD 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Indicated for external application on the skin and compatible with professional cosmetic protocols for needle-free mesotherapy, superficial cosmetic microneedling and non-invasive transdermal delivery systems using professional equipment

Glucagon-like peptide-1 receptor (GLP-1R) agonists are effective anti-obesity drugs but their use is limited by side effects

A double-blind, randomized controlled trial demonstrated that L-theanine intake resulted in a statistically significant reduction in heart rate and salivary immunoglobulin A (a physiological stress marker) during acute mental stress

GLP-1 Agonist Complications

The accumulation of AGEs in blood vessels also reduces NO production, resulting in increased vascular resistance and hypertension 16

PMID: 34885664 van Beek N, Bod E, Kromminga A, Gspr E, Meyer K, Zmijewski MA et al